Healthcare Global Enterprises Share Price

Conference Call with Healthcare Global Enterprises Management and Analysts on Q1FY27 Performance and Outlook. Listen to the <a href="https://youtu.be/g0kbKQmoWmQ">full earnings transcript</a>. <br>

• Trendlyne
• 18 minutes 27 seconds ago

<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Healthcare Global Enterprises announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Revenue from Operations:</strong> The consolidated revenue stood at Rs 69,339 lakh in Q1FY27, representing a YoY increase of 13.34% from Rs 61,180 lakh in Q1FY26 and a QoQ growth of 6.63% from Rs 65,029 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Income:</strong> Total income for Q1FY27 was Rs 70,723 lakh, showing a YoY growth of 14.07% compared to Rs 61,999 lakh in Q1FY26 and an increase of 6.29% from Rs 66,540 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Profit Before Exceptional Items and Tax:</strong> Profit stood at Rs 2,503 lakh in Q1FY27, up by 109.98% YoY compared to Rs 1,192 lakh in Q1FY26, but down 24.52% QoQ from Rs 3,316 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Net Profit for the Period:</strong> The company reported a net profit of Rs 1,646 lakh in Q1FY27, reflecting a significant YoY growth of 175.25% from Rs 598 lakh in Q1FY26 and a QoQ increase of 307.43% from Rs 404 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Comprehensive Income:</strong> Total comprehensive income reached Rs 1,695 lakh in Q1FY27, marking a YoY growth of 172.07% over Rs 623 lakh in Q1FY26 and a QoQ increase of 197.89% from Rs 569 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Earnings Per Share (EPS):</strong> Basic and Diluted EPS for Q1FY27 stood at Rs 0.92, compared to Rs 0.34 in Q1FY26 and Rs 0.15 in Q4FY26.</li> </ul> <p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Revenue from Operations:</strong> Standalone revenue was Rs 37,525 lakh in Q1FY27, reflecting a YoY growth of 15.13% from Rs 32,593 lakh in Q1FY26 and a QoQ growth of 7.68% from Rs 34,847 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Income:</strong> Standalone total income stood at Rs 38,622 lakh in Q1FY27, an increase of 15.28% YoY from Rs 33,503 lakh in Q1FY26 and up 5.78% QoQ from Rs 36,513 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Profit Before Tax:</strong> Standalone profit before tax for Q1FY27 was Rs 748 lakh, showing a YoY growth of 42.75% from Rs 524 lakh in Q1FY26, but a QoQ decline from Rs 3,857 lakh (before exceptional items) in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Net Profit for the Period:</strong> The standalone net profit reached Rs 558 lakh in Q1FY27, a YoY growth of 61.74% from Rs 345 lakh in Q1FY26 and a QoQ growth of 264.71% over Rs 153 lakh in Q4FY26.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Total Comprehensive Income:</strong> This stood at 558 lakh in Q1FY27, compared to 345 lakh in Q1FY26 and 142 lakh in Q4FY26.</li> </ul> <p _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Divestment of BACC:</strong> During the current quarter, the company completed the divestment of its entire equity interest in BACC Healthcare Private Limited for a consideration of 3,764 lakh on June 29, 2026. A resulting gain of 296 lakh has been recognized in other income.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Acquisition of VHCRPL:</strong> On April 13, 2026, the company completed the acquisition of an additional 34% equity share capital of Vizag Hospital And Cancer Research Centre Private Limited (VHCRPL) for an aggregate purchase consideration of 15,450 lakh.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Subsidiary Investment:</strong> The Board approved a further investment of up to Rs 16 crore in HCG Rajkot Hospitals LLP, a wholly owned subsidiary of the company.</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Employee Stock Options:</strong> Subsequent to the quarter, shareholders approved the introduction and adoption of the HCG Employee Stock Option Scheme 2026 (HCG ESOS 2026).</li> <li _ngcontent-ng-c2478508423=""><strong _ngcontent-ng-c2478508423="">Cost Auditor Appointment:</strong> The Board approved the re-appointment of M/s. Rao Murthy & Associates as the Cost Auditor for the financial year 2026-27.</li> </ul> <p><strong>B. S. Ajaikumar, Founder & Non-Executive Chairman, HealthCare Global Enterprises, said:</strong> "The strong start to FY27 reflects the resilience of HCG's integrated oncology model and our unwavering commitment to clinical excellence. Over the years, we have consistently invested in expanding access to advanced cancer care while building an institution that combines cutting-edge technology, world-class medical expertise, and compassionate patient care. As we continue to strengthen our network through strategic capacity expansion and focused investments in innovation, we remain committed to shaping the future of oncology and delivering sustainable long-term value for our patients, clinicians, shareholders, and the communities we serve."</p> <p><strong>Manish Mattoo, Executive Director & CEO, HealthCare Global Enterprises (HCG), said:</strong> "We have started FY27 on a strong note, with revenue growing 13% YoY to Rs 6,951 million. Excluding North Bangalore hospital, 16 of our 25 centres recorded their highest-ever quarterly revenues, reflecting broad-based growth across our network and sustained demand for our oncology services.</p> <p>Our focus on increasing the share of high-complexity oncology care and non-institutional business continues to strengthen the quality of our revenue. Non-institutional revenue grew 17% year-on-year, with its contribution increasing from 67% to 69%, while Adjusted EBITDA, grew 20% to Rs 1,339 million, with margins improving to 19.4%.</p> <p>We are encouraged by the strong response to our new North Bangalore hospital, which is expected to contribute meaningfully as insurance empanelment progress and onboarded doctors ramp up their practices. Looking ahead, we remain committed to strengthening clinical leadership, expanding capacity in high-potential markets, and delivering sustainable, profitable growth while enhancing access to world-class cancer care."</p> <p><a class="lb" href="/get-document/post/pdf/5770174/" target="_blank">Result PDF</a></p>

• Trendlyne
• 2 hours 45 minutes ago

Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.

• BSE India
• 19 hours 19 minutes ago